Over the past decade, science has greatly advanced our understanding of interdependent feedback mechanisms involving the heart, lung, and kidney. Organ injury is the consequence of maladaptive neurohormonal activation, oxidative stress, abnormal immune cell signaling, and a host of other mechanisms that precipitate adverse functional and structural changes. The presentation of interorgan crosstalk may include an acute, chronic, or acute on chronic timeframe. We review the current, state-of-the-art understanding of cardio-pulmonary-renal interactions and their related pathophysiology, perpetuating nature, and cycles of increased susceptibility and reciprocal progression. To this end, we present a multidisciplinary approach to frame the diverse spectrum of published observations on the topic. Assessment of organ functional reserve and use of biomarkers are valuable clinical strategies to screen and detect disease, assist in diagnosis, assess prognosis, and predict recovery or progression to chronic disease. (J Am Coll Cardiol 2015;65:2433-48)
LUNG IN ORGAN CROSSTALK: THE PULMONOLOGIST'S VIEW
Open to environmental influence, the lung is a highly immunologic organ, representing a gateway to the environment. The lung has critical pathophysiological connections to the failing heart and kidney ( Figure 1A ). and exhaled nitric oxide (3, 4) . The concept of subclinical lung injury (e.g., due to previous smoking) takes into account that even asymptomatic events can lead to increased future susceptibility to respiratory failure events, and new diagnostic techniques may provide early detection (5,6).
Circulating factors have been implicated in the pathogenesis of pulmonary inflammation following renal and hepatic ischemia/reperfusion injury in animal models and humans (7) (8) (9) . In ischemic AKI, experimental studies demonstrate increased pulmonary vascular permeability, cellular apoptosis, alveolar hemorrhage, and leukocyte trafficking due to the production and/or decreased clearance of mediators of lung injury (2) . Intraluminal neutrophils contribute through phagocytosis and release of mediators, including reactive oxygen species and proteases, and activation of dendritic cells, augmenting the immune response. Pro-inflammatory cytokines produced by renal tubular cells as well as white blood cells include TNF-a and IL-1b and -6. Conversely, there are counterbalancing cell signaling peptides, including the anti-inflammatory IL-10, which has been shown to reduce lung injury in experimental models (2) .
Delayed recovery of kidney function may impair resolution of lung inflammation post-AKI (10). The altered mechanisms for water transport in pulmonary edema are described in detail in the "Uremic Lung" section. (10, 13) . In addition, fluid overload and venous congestion is an independent predictor of increased mortality in AKI that is thought to further contribute to respiratory complications (14) . Here, the goal of optimal fluid management for recovery of both organs is an area of active study (10) . Furthermore, the role of inhaled nitric oxide for alleviation of ARDS and altering renal function has to be defined, including its anti-inflammatory properties (15) . Sev- Although the resultant reduction in vascular permeability is initially protective against pulmonary edema and can be seen as a restorative mechanism, the process can cause a restrictive, poorly compliant lung with impaired gas exchange, and reduced exercise capacity. The lung diffusion capacity for carbon monoxide is one of the most clinically-valuable tests to assess the alveolar-capillary membrane. In acute decompensated HF, it can be normal or elevated due to an increased alveolar capillary blood volume, whereas the previously-mentioned mechanisms can lead to its impairment in chronic HF (25) . In CKD, a Distant organ damage is often proportional to duration of HF and represents a daily multidisciplinary challenge. Recently, a TNM-like method was proposed for HF staging, which includes the characterization "H" for heart, "L" for lung, and "M" for malfunction of other organs including the kidney (39) . Most distant organ malfunctions (e.g., liver, kidney, or bowel) are the result of right-sided HF and acute on chronic venous congestion (40) . Additionally, AKI occurs in 25% to 33% of acute decompensated HF, which is an independent risk factor for prolonged hospitalization, need for renal replacement therapies, readmission, increased stroke risk, and mortality (41) . In 60% of cases of acutely decompensated HF, AKI can be seen as an exacerbation of previously-diagnosed CKD, whereas in chronic HF, CKD has been reported as a comorbidity in 26% to 63% (42) . Oxidative stress has been implicated as the final common pathway of injury in various pathological systems that are prevalent in cardiac, pulmonary, and renal disorders (1, 44) . Accumulation of oxidativedamage products and failure to adapt to reactive oxygen species stress may result in an immune system activation and a proinflammatory and/or profibrotic milieu to generate functional and structural abnormalities, and consequently evoke cell death.
RIGHT VENTRICULAR STRESS AND VENOUS CONGESTION.
Pulmonary vascular resistance is in constant interplay with right ventricular function. In the normal state, the right ventricle is a thin-walled, compliant, low-pressure chamber that pumps the same stroke volume as the left ventricle, but with z25% of the stroke work due to the typically low resistance of the pulmonary vasculature (45) . In PH, the stressed heart tries to balance pre-load and afterload to accommodate increased pulmonary vascular resistance.
Resultant neurohormonal activation (endothelin, arginine vasopressin) leads to water and salt retention, worsening venous congestion, and further reduced cardiac output (46) .
In HF, renal failure has traditionally been thought to be caused by renal hypoperfusion due to lowoutput failure. However, most hospitalizations for acute decompensated HF occur because of symptoms CKD AND FIBROSIS. The high prevalence and burden of CKD is well established and can represent the origin and/or continuum of chronic cardiopulmonary disorders. The concept of subclinical AKI was discussed, and early pathological changes can occur without apparent clinical presentation due to the high renal adaptability, but they still depict a slowly progressing degenerative process that is both local and systemic. Once the adaptive threshold is reached, the progression to CKD is fast. It is generally accepted that all primary causes of CKD share a common pathogenic pathway of progressive renal injury due to the destructive consequences of fibrosis. As fibrosis increases, the nephron that normally has a potent regenerative capacity loses this ability, leading to apoptosis. Proteinuria is a surrogate marker of CKD progression and reflects endothelial dysfunction. Even a modest increase in albuminuria is associated with chronic pulmonary disorders (76), right ventricular/LV remodeling, and adverse cardiovascular outcomes (77) , although by the time proteinuria manifests, renal structural damage has already occurred. Here, clinical and emerging biomarkers (e.g., galectin-3) have been identified (78) . Still, it is important to underscore that most CKD patients will never reach the point of needing renal replacement therapy. They are more likely to die prematurely due to accelerated cardiovascular diseases. 
